Skip to search formSkip to main contentSkip to account menu

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

Known as: PARP Polymerase Inhibitor, Polyadenosine 5'-Diphosphoribose Polymerase Inhibitor, Poly (ADP Ribose) Polymerase Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The addition of the PARP inhibitor veliparib to carboplatin and paclitaxel offered significant improvement to patients with HER2… 
2019
2019
A phase I/II trial tested the combination of niraparib and pembrolizumab in patients with recurrent ovarian carcinoma. 
2017
2017
Large-scale genomic studies have demonstrated that approximately 50% of high-grade serous ovarian cancers (HGSOCs) harbor genetic… 
2012
2012
Cocaine abuse is associated with multiple health problems including occasional hepatic failure and death. The mechanism of… 
2008
2008
Student Researcher: Boriss Losso, Catholic High School Mentors: Jeho Shin, Viktor R. Drel, Irina G. Obrosova, Pennington…